F
Fluxion Therapeutics develops Physiomics, a new field in biotech that captures dynamic cell activity using automated electrical recordings and AI analysis. This approach provides functional, time-based insights into cellular behavior that static assays cannot capture. The platform delivers rich, multi-dimensional data to enhance drug discovery and development decisions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Fluxion Therapeutics develops Physiomics, a new field in biotech that captures dynamic cell activity using automated electrical recordings and AI analysis. This approach provides functional, time-based insights into cellular behavior that static assays cannot capture. The platform delivers rich, multi-dimensional data to enhance drug discovery and development decisions.